Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73-Reference-Cited by-同舟云学术

Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73

Published:2012-10-31 Issue:4 Volume:11 Page:161-171
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Liang Hongyan¹,Block Timothy M.¹,Wang Mengjun¹,Nefsky Bradley¹,Long Ronald¹,Hafner Julie²,Mehta Anand S.¹,Marrero Jorge³,Gish Robert⁴,Norton Pamela A.¹

Affiliation:

1. Department of Microbiology and Immunology, Drexel Institute for Biotechnology and Virology Research, Drexel University College of Medicine, Doylestown, PA, USA

2. Immunotope, Inc., Doylestown, PA, USA

3. Division of Gastroenterology, University of Michigan, Ann Arbor, MI, USA

4. Division of Clinical Hepatology, Department of Clinical Medicine and Center for Hepatobiliary Disease and Abdominal Transplantation, UCSD Medical Center, San Diego, CA, USA

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential use of Oncostatin M in Critically ill Patients with acute Kidney Injury;Open Access Macedonian Journal of Medical Sciences;2024-07-20

2. Elucidating the multifaceted role of MGAT1 in hepatocellular carcinoma: integrative single-cell and spatial transcriptomics reveal novel therapeutic insights;Frontiers in Immunology;2024-07-16

3. Tumor‐associated macrophages: The key player in hepatoblastoma microenvironment and the promising therapeutic target;Microbiology and Immunology;2024-06-25

4. Liver organoid culture methods;Cell & Bioscience;2023-11-01

5. The clinical relevance of OSM in inflammatory diseases: a comprehensive review;Frontiers in Immunology;2023-09-29